Literature DB >> 16434273

Influence of surgical strategies on outcome after the Norwood procedure.

Massimo Griselli1, Simon P McGuirk, Oliver Stümper, Andrew J B Clarke, Paul Miller, Rami Dhillon, John G C Wright, Joseph V de Giovanni, David J Barron, William J Brawn.   

Abstract

OBJECTIVE: The study objective was to identify how the evolution of surgical strategies influenced the outcome after the Norwood procedure.
METHODS: From 1992 to 2004, 367 patients underwent the Norwood procedure (median age, 4 days). Three surgical strategies were identified on the basis of arch reconstruction and source of pulmonary blood flow. The arch was refashioned without extra material in group A (n = 148). The arch was reconstructed with a pulmonary artery homograft patch in groups B (n = 145) and C (n = 74). Pulmonary blood flow was supplied by a modified Blalock-Taussig shunt in groups A and B. Pulmonary blood flow was supplied by a right ventricle to pulmonary artery conduit in group C. Early mortality, actuarial survival, and freedom from arch reintervention or pulmonary artery patch augmentation were analyzed.
RESULTS: Early mortality was 28% (n = 102). Actuarial survival was 62% +/- 3% at 6 months. Early mortality was lower in group C (15%) than group A (31%) or group B (31%; P <.05). Actuarial survival at 6 months was better in group C (78% +/- 5%) than group A (59% +/- 5%) or group B (58% +/- 4%; P <.05). Fifty-three patients (14%) had arch reintervention. Freedom from arch reintervention was 76% +/- 3% at 1 year, with univariable analysis showing no difference among groups A, B, and C (P =.71). One hundred patients (27%) required subsequent pulmonary artery patch augmentation. Freedom from patch augmentation was 61% +/- 3% at 1 year, and was lower in group C (3% +/- 3%) than group A (80% +/- 4%) or group B (72% +/- 5%; P <.05).
CONCLUSIONS: Survival after the Norwood procedure improved after the introduction of a right ventricle to pulmonary artery conduit, but a greater proportion of patients required subsequent pulmonary artery patch augmentation. The type of arch reconstruction did not affect the incidence of arch reintervention.

Entities:  

Mesh:

Year:  2006        PMID: 16434273     DOI: 10.1016/j.jtcvs.2005.08.066

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Rudimentary right ventricle to pulmonary artery shunt in the Norwood procedure.

Authors:  Atsushi Tateishi; Masaaki Kawada; Hideki Morita; Mamoru Takeuchi; Naoyuki Taga; Yoji Otsuka; Osamu Okada; Koichi Kataoka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-12-18

2.  Aortic arch reconstruction in newborns with an autologous pericardial patch: contemporary results.

Authors:  Massimo Bernabei; Rafik Margaryan; Luigi Arcieri; Giacomo Bianchi; Vitali Pak; Bruno Murzi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-07

3.  Follow-up study of pulmonary artery configuration in hypoplastic left heart syndrome.

Authors:  Toshihide Nakano; Koji Fukae; Hiromichi Sonoda; Tsuyoshi Tachibana; Masaki Kajimoto; Yusuke Ando; Hideaki Kado
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-02-24

4.  Hybrid transcatheter-surgical palliation: basis for univentricular or biventricular repair: the Giessen experience.

Authors:  Hakan Akintürk; Ina Michel-Behnke; Klaus Valeske; Matthias Mueller; Josef Thul; Juergen Bauer; Karl-Juergen Hagel; Dietmar Schranz
Journal:  Pediatr Cardiol       Date:  2007-02-15       Impact factor: 1.655

5.  Does the size of pulmonary artery impact on recoarctation of the aorta after the Norwood procedure without patch?

Authors:  Yasuyuki Kobayashi; Yasuhiro Kotani; Takuya Kawabata; Yosuke Kuroko; Shunji Sano; Shingo Kasahara
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29

6.  Early Outcomes of the Norwood Procedure in a Reference Center in Brazil.

Authors:  Rodrigo Freire Bezerra; Juliana Torres Pacheco; Sônia Meiken Franchi; Rosangela Belbuche Fittaroni; José Francisco Baumgratz; Rodrigo Moreira Castro; Luciana da Fonseca da Silva; José Pedro da Silva
Journal:  Arq Bras Cardiol       Date:  2022-08       Impact factor: 2.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.